Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells

K. W. Ng, Nicola Partridge, M. Niall, T. J. Martin

Research output: Contribution to journalArticle

Abstract

Studies were carried out to identify and characterize the receptors for epidermal growth factor (EGF) in osteoblast-rich newborn rat calvarial cells and in 4 clonal lines derived from a transplantable rat osteogenic sarcoma with a well-characterized osteoblast-like phenotype. The cells were grown in monolayer culture in replicate wells; 40,000-50,000 cpm125I-labeled mouse EGF with a specific activity of 100-120 μCi/μg was added to each well. Binding studies were carried out at 37°C. Binding of125I-labeled EGF was specific, saturable, reversible, and pH dependent. Maximum binding occurred 2 h after addition of the tracer. Thereafter, cell-bound radioactivity decreased to reach a plateau of 15-20% of maximum binding at 24 h. This observation is consistent with internalization and processing of the receptor-hormone complex as has been shown with other EGF target cells. Scatchard analyses revealed a single class of high-affinity binding sites in the normal and malignant osteoblast-like cells. Dissociation constants (KD) in the clonal lines ranged from 2.3 × 10-10M to 4.7 × 10-10M with receptor number per cell ranging from 25,000 to 33,000. The calvarial cells had a KD of 2.0 × 10-10M with 14,000 receptors per cell. In both the normal and malignant cell strains, EGF was found to increase incorporation of3H-labeled thymidine into acid-precipitable macromolecules. EGF has been shown to stimulate bone resorption; however, studies in organ cultures have not identified the target cell for EGF. The present results point to an interaction of EGF with osteoblasts.

Original languageEnglish (US)
Pages (from-to)298-303
Number of pages6
JournalCalcified Tissue International
Volume35
Issue number1
DOIs
StatePublished - Dec 1983

Fingerprint

Osteosarcoma
Osteoblasts
Epidermal Growth Factor
Bone and Bones
ErbB Receptors
Organ Culture Techniques
Bone Resorption
Thymidine
Radioactivity
Cell Count
Binding Sites
Hormones
Phenotype
Acids

Keywords

  • Epidermal growth factor
  • Osteoblasts
  • Receptors

ASJC Scopus subject areas

  • Endocrinology
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells. / Ng, K. W.; Partridge, Nicola; Niall, M.; Martin, T. J.

In: Calcified Tissue International, Vol. 35, No. 1, 12.1983, p. 298-303.

Research output: Contribution to journalArticle

@article{d7bd2773dca14c85826a818f641529a6,
title = "Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells",
abstract = "Studies were carried out to identify and characterize the receptors for epidermal growth factor (EGF) in osteoblast-rich newborn rat calvarial cells and in 4 clonal lines derived from a transplantable rat osteogenic sarcoma with a well-characterized osteoblast-like phenotype. The cells were grown in monolayer culture in replicate wells; 40,000-50,000 cpm125I-labeled mouse EGF with a specific activity of 100-120 μCi/μg was added to each well. Binding studies were carried out at 37°C. Binding of125I-labeled EGF was specific, saturable, reversible, and pH dependent. Maximum binding occurred 2 h after addition of the tracer. Thereafter, cell-bound radioactivity decreased to reach a plateau of 15-20{\%} of maximum binding at 24 h. This observation is consistent with internalization and processing of the receptor-hormone complex as has been shown with other EGF target cells. Scatchard analyses revealed a single class of high-affinity binding sites in the normal and malignant osteoblast-like cells. Dissociation constants (KD) in the clonal lines ranged from 2.3 × 10-10M to 4.7 × 10-10M with receptor number per cell ranging from 25,000 to 33,000. The calvarial cells had a KD of 2.0 × 10-10M with 14,000 receptors per cell. In both the normal and malignant cell strains, EGF was found to increase incorporation of3H-labeled thymidine into acid-precipitable macromolecules. EGF has been shown to stimulate bone resorption; however, studies in organ cultures have not identified the target cell for EGF. The present results point to an interaction of EGF with osteoblasts.",
keywords = "Epidermal growth factor, Osteoblasts, Receptors",
author = "Ng, {K. W.} and Nicola Partridge and M. Niall and Martin, {T. J.}",
year = "1983",
month = "12",
doi = "10.1007/BF02405050",
language = "English (US)",
volume = "35",
pages = "298--303",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells

AU - Ng, K. W.

AU - Partridge, Nicola

AU - Niall, M.

AU - Martin, T. J.

PY - 1983/12

Y1 - 1983/12

N2 - Studies were carried out to identify and characterize the receptors for epidermal growth factor (EGF) in osteoblast-rich newborn rat calvarial cells and in 4 clonal lines derived from a transplantable rat osteogenic sarcoma with a well-characterized osteoblast-like phenotype. The cells were grown in monolayer culture in replicate wells; 40,000-50,000 cpm125I-labeled mouse EGF with a specific activity of 100-120 μCi/μg was added to each well. Binding studies were carried out at 37°C. Binding of125I-labeled EGF was specific, saturable, reversible, and pH dependent. Maximum binding occurred 2 h after addition of the tracer. Thereafter, cell-bound radioactivity decreased to reach a plateau of 15-20% of maximum binding at 24 h. This observation is consistent with internalization and processing of the receptor-hormone complex as has been shown with other EGF target cells. Scatchard analyses revealed a single class of high-affinity binding sites in the normal and malignant osteoblast-like cells. Dissociation constants (KD) in the clonal lines ranged from 2.3 × 10-10M to 4.7 × 10-10M with receptor number per cell ranging from 25,000 to 33,000. The calvarial cells had a KD of 2.0 × 10-10M with 14,000 receptors per cell. In both the normal and malignant cell strains, EGF was found to increase incorporation of3H-labeled thymidine into acid-precipitable macromolecules. EGF has been shown to stimulate bone resorption; however, studies in organ cultures have not identified the target cell for EGF. The present results point to an interaction of EGF with osteoblasts.

AB - Studies were carried out to identify and characterize the receptors for epidermal growth factor (EGF) in osteoblast-rich newborn rat calvarial cells and in 4 clonal lines derived from a transplantable rat osteogenic sarcoma with a well-characterized osteoblast-like phenotype. The cells were grown in monolayer culture in replicate wells; 40,000-50,000 cpm125I-labeled mouse EGF with a specific activity of 100-120 μCi/μg was added to each well. Binding studies were carried out at 37°C. Binding of125I-labeled EGF was specific, saturable, reversible, and pH dependent. Maximum binding occurred 2 h after addition of the tracer. Thereafter, cell-bound radioactivity decreased to reach a plateau of 15-20% of maximum binding at 24 h. This observation is consistent with internalization and processing of the receptor-hormone complex as has been shown with other EGF target cells. Scatchard analyses revealed a single class of high-affinity binding sites in the normal and malignant osteoblast-like cells. Dissociation constants (KD) in the clonal lines ranged from 2.3 × 10-10M to 4.7 × 10-10M with receptor number per cell ranging from 25,000 to 33,000. The calvarial cells had a KD of 2.0 × 10-10M with 14,000 receptors per cell. In both the normal and malignant cell strains, EGF was found to increase incorporation of3H-labeled thymidine into acid-precipitable macromolecules. EGF has been shown to stimulate bone resorption; however, studies in organ cultures have not identified the target cell for EGF. The present results point to an interaction of EGF with osteoblasts.

KW - Epidermal growth factor

KW - Osteoblasts

KW - Receptors

UR - http://www.scopus.com/inward/record.url?scp=0020957321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020957321&partnerID=8YFLogxK

U2 - 10.1007/BF02405050

DO - 10.1007/BF02405050

M3 - Article

VL - 35

SP - 298

EP - 303

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 1

ER -